查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1613041

可待因市場：按配方、等級、應用、分銷管道、最終用戶分類 - 2025-2030 年全球預測

Codeine Market by Formulation (Capsule, Syrup, Tablet), Grade (Laboratory Grade, Pharmaceutical Grade), Application, Distribution Channel, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年可待因市場價值為39.3億美元，預計到2024年將達到41.1億美元，複合年成長率為4.65%，預計到2030年將達到54億美元。

可待因是鴉片劑，由於其廣泛的用途和疼痛管理的需要，在製藥業中發揮著重要作用。可待因主要涵蓋處方藥和非處方藥，如錠劑、膠囊和糖漿。可待因的需求源自於其緩解輕度至中度疼痛的功效以及抑制咳嗽的效用。就用途而言，可待因被醫療保健提供者用於多種治療目的，主要透過藥房和醫院分銷。最終用途範圍還包括需要疼痛管理的患者，創造了持續的需求，推動市場成長。影響成長的關鍵因素包括慢性疼痛疾病發病率的增加、對疼痛管理解決方案的需求增加以及對有效治療方案的認知不斷提高。然而，潛在的濫用和監管限制對市場成長構成挑戰並引起關注。鴉片類藥物危機導致監管加強，這對擴張產生了負面影響。然而，在開發更安全、成癮性較低的可待因製劑以及探索可待因衍生物的替代天然來源方面存在新的商機。此外，製劑設計的潛在技術進步可以增強藥物傳遞方法並提供競爭優勢。創新還可以集中於改進合成生物技術，以更永續地生產可待因。研究罌粟植物的基因改造及其生物合成途徑可能為可待因生產效率提供新的見解。市場相關人員還可以從投資病患教育計畫中受益，以提高安全使用意識，建立忠實的消費者基礎，同時解決社會問題。這些策略加上遵守不斷變化的法律環境，可能會增強市場影響力並確保永續成長。

主要市場統計
基準年[2023] 39.3億美元
預計年份 [2024] 41.1億美元
預測年份 [2030] 54億美元
複合年成長率（%） 4.65%

市場動態：揭示快速發展的可待因市場的關鍵市場洞察

可待因市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性疼痛和咳嗽的盛行率增加
    • 提供結構化法規結構以確保受管制物質的安全分配
  • 市場限制因素
    • 可待因的生產和商業化成本高
  • 市場機會
    • 藥廠與科研機構合作開發可待因創新且高效使用
    • 控制釋放製劑不斷進步
  • 市場挑戰
    • 使用可待因的仿冒品盛行

波特的五力：駕馭可待因市場的策略工具

波特的五力架構是了解可待因市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解對可待因市場的外部影響

外部宏觀環境因素在塑造可待因市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解可待因市場的競爭狀況

對可待因市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣可待因市場供應商績效評估

FPNV 定位矩陣是評估可待因市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了可待因市場的成功之路

可待因市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性疼痛和咳嗽症狀加重
      • 存在結構化的法規結構，以確保受管制物質的安全流動
    • 抑制因素
      • 可待因的生產和商業化成本很高。
    • 機會
      • 藥廠與科研機構聯合研發的可待因創新高效使用
      • 控制釋放的進展
    • 任務
      • 假冒可待因仿冒品的傳播
  • 市場區隔分析
    • 處方：由於患者依從性較高，糖漿優於其他製劑
    • 用途：可待因，被認為是呼吸道疾病咳嗽反射的抑制劑
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 可待因處方市場

  • 膠囊
  • 糖漿
  • 錠劑

第7章可待因市場：依等級

  • 實驗室級
  • 醫藥級

第8章可待因市場：依應用分類

  • 止咳藥
  • 抑制腹瀉
  • 疼痛管理

第9章可待因市場：依分銷管道分類

  • 離線
    • 醫院/診所
    • 藥局
  • 線上

第 10 章 可待因市場：依最終使用者分類

  • 成人
  • 小兒科

第11章美洲可待因市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區可待因市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的可待因市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 強效鎮痛藥的開發進展
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Accord Healthcare by Intas Pharmaceuticals
  • Advik Pharma
  • AstraEureka Pharmaceuticals
  • Bristol Laboratories Limited
  • Crescent Pharma Limited
  • Johnson Matthey Plc
  • Noramco, Inc.
  • Omnica Laboratories
  • Pfizer Inc.
  • Professional Compounding Centers of America, Inc.
  • SANOFI WINTHROP INDUSTRIE
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-99555D550530

The Codeine Market was valued at USD 3.93 billion in 2023, expected to reach USD 4.11 billion in 2024, and is projected to grow at a CAGR of 4.65%, to USD 5.40 billion by 2030.

Codeine, an opiate used to treat pain, cough, and diarrhea, plays a crucial role in the pharmaceutical industry due to its widespread application and necessity in pain management. The scope of codeine encompasses prescription and over-the-counter medications, predominantly in the form of tablets, capsules, and syrups. The necessity of codeine stems from its efficacy in providing relief for mild to moderate pain and its utility in suppressing coughs. In terms of application, codeine is utilized by healthcare providers for diverse therapeutic purposes and is primarily distributed through pharmacies and hospitals. The end-use scope includes patients requiring pain management, creating a constant demand that drives market growth. Key factors influencing growth include an increasing incidence of chronic pain conditions, which elevate the demand for pain management solutions, and heightened awareness of effective treatment options. However, the market is gaining attention due to potential misuse and regulatory limitations which challenge its growth. The opioid crisis has led to stricter regulations, negatively impacting expansion. Nevertheless, an emerging opportunity lies in developing safer, less addictive codeine formulations and exploring alternative natural sources for codeine derivatives. Furthermore, potential technological advancements in pharmaceutical formulation design could enhance drug delivery methods, providing a competitive edge. Innovation may also focus on improving synthetic biology techniques to produce codeine more sustainably. Researching genetic modifications in poppy plants or their biosynthetic pathways could yield new insights into codeine production efficiency. Market players can also benefit from investing in patient education programs to enhance safe use awareness, thus creating a loyal consumer base while addressing societal concerns. These strategies, combined with adherence to evolving legal landscapes, could strengthen market presence and ensure sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.93 billion
Estimated Year [2024] USD 4.11 billion
Forecast Year [2030] USD 5.40 billion
CAGR (%) 4.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Codeine Market

The Codeine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic pain and cough conditions
    • Availability of structured regulatory frameworks to ensure the safe distribution of controlled substances
  • Market Restraints
    • High costs of production and commercialization of codeine
  • Market Opportunities
    • Collaborative developments between pharmaceutical and research institutions to innovative and efficient uses of codeine
    • Rising advancements in controlled-release formulations
  • Market Challenges
    • Prevalence of counterfeit products with codeine

Porter's Five Forces: A Strategic Tool for Navigating the Codeine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Codeine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Codeine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Codeine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Codeine Market

A detailed market share analysis in the Codeine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Codeine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Codeine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Codeine Market

A strategic analysis of the Codeine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Codeine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accord Healthcare by Intas Pharmaceuticals, Advik Pharma, AstraEureka Pharmaceuticals, Bristol Laboratories Limited, Crescent Pharma Limited, Johnson Matthey Plc, Noramco, Inc., Omnica Laboratories, Pfizer Inc., Professional Compounding Centers of America, Inc., SANOFI WINTHROP INDUSTRIE, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Codeine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Formulation, market is studied across Capsule, Syrup, and Tablet.
  • Based on Grade, market is studied across Laboratory Grade and Pharmaceutical Grade.
  • Based on Application, market is studied across Cough Suppression, Diarrhea Suppression, and Pain Management.
  • Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Pharmacies.
  • Based on End-User, market is studied across Adults and Pediatrics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic pain and cough conditions
      • 5.1.1.2. Availability of structured regulatory frameworks to ensure the safe distribution of controlled substances
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of production and commercialization of codeine
    • 5.1.3. Opportunities
      • 5.1.3.1. Collaborative developments between pharmaceutical and research institutions to innovative and efficient uses of codeine
      • 5.1.3.2. Rising advancements in controlled-release formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Prevalence of counterfeit products with codeine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Syrup preferred over other formulations owing to higher patient compliance
    • 5.2.2. Applications: Codeine recognized as a suppressor of cough reflex in respiratory conditions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Codeine Market, by Formulation

  • 6.1. Introduction
  • 6.2. Capsule
  • 6.3. Syrup
  • 6.4. Tablet

7. Codeine Market, by Grade

  • 7.1. Introduction
  • 7.2. Laboratory Grade
  • 7.3. Pharmaceutical Grade

8. Codeine Market, by Application

  • 8.1. Introduction
  • 8.2. Cough Suppression
  • 8.3. Diarrhea Suppression
  • 8.4. Pain Management

9. Codeine Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Offline
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Pharmacies
  • 9.3. Online

10. Codeine Market, by End-User

  • 10.1. Introduction
  • 10.2. Adults
  • 10.3. Pediatrics

11. Americas Codeine Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Codeine Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Codeine Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Advancements in Developing Enhanced Pain Relief Medications
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Accord Healthcare by Intas Pharmaceuticals
  • 3. Advik Pharma
  • 4. AstraEureka Pharmaceuticals
  • 5. Bristol Laboratories Limited
  • 6. Crescent Pharma Limited
  • 7. Johnson Matthey Plc
  • 8. Noramco, Inc.
  • 9. Omnica Laboratories
  • 10. Pfizer Inc.
  • 11. Professional Compounding Centers of America, Inc.
  • 12. SANOFI WINTHROP INDUSTRIE
  • 13. Sun Pharmaceutical Industries Ltd.
  • 14. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. CODEINE MARKET RESEARCH PROCESS
  • FIGURE 2. CODEINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CODEINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CODEINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CODEINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CODEINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CODEINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CODEINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CODEINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CODEINE MARKET DYNAMICS
  • TABLE 7. GLOBAL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CODEINE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CODEINE MARKET SIZE, BY SYRUP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CODEINE MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CODEINE MARKET SIZE, BY LABORATORY GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CODEINE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CODEINE MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CODEINE MARKET SIZE, BY DIARRHEA SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CODEINE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CODEINE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CODEINE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CODEINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CODEINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CODEINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CODEINE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CODEINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA CODEINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CODEINE MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CODEINE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM CODEINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM CODEINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM CODEINE MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM CODEINE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. CODEINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. CODEINE MARKET, FPNV POSITIONING MATRIX, 2023